mHealth Solutions Market: Global Forecast to 2031

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3.1 MHEALTH SOLUTIONS MARKET OVERVIEW
3.2 MHEALTH SOLUTIONS MARKET, BY OFFERING & REGION
3.3 MHEALTH SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms
4.2.1.2 Rising focus on patient-centric healthcare delivery
4.2.1.3 Rapid adoption of wearables expands connected mHealth ecosystems
4.2.1.4 Chronic disease burden drives demand for remote monitoring and connected devices
4.2.2 RESTRAINTS
4.2.2.1 Complexity of regulatory landscape
4.2.2.2 Fragmentation of mHealth ecosystem
4.2.2.3 Interoperability constraints
4.2.3 OPPORTUNITIES
4.2.3.1 AI and predictive analytics expand mHealth capabilities
4.2.3.2 Growing adoption across emerging markets
4.2.3.3 Strategic partnerships and collaborations among healthcare companies and mHealth providers
4.2.3.4 Telehealth growth expands mobile care delivery
4.2.4 CHALLENGES
4.2.4.1 Reimbursement barriers restrict wider mHealth adoption
4.2.4.2 Concerns associated with data security
4.2.4.3 Rapid Technology Evolution Increases mHealth Development Complexity
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025)
5.5.2 INDICATIVE PRICE FOR MHEALTH SOLUTIONS MARKET, BY REGION (2025)
5.6 KEY CONFERENCES AND EVENTS, 2026-2027
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
5.9.1 CASE 1: CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA)
5.9.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM
5.9.3 CASE STUDY 3: APPLE & NHS TEAMS
5.10 IMPACT OF 2025 US TARIFF - OVERVIEW
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END USERS
5.10.5.1 Healthcare providers
5.10.5.2 Healthcare payers
5.10.5.3 Patients and consumers
5.10.5.4 Other end users (Academic institutes, research centers, government bodies, etc.)

6.1 KEY EMERGING TECHNOLOGIES
6.1.1 AI AND MACHINE LEARNING
6.1.2 5G/6G CONNECTIVITY
6.1.3 DIGITAL BIOMARKERS
6.1.4 COMPLEMENTARY TECHNOLOGIES
6.1.5 CONNECTED MEDICAL DEVICES
6.1.6 CLOUD COMPUTING
6.1.7 TELEMEDICINE PLATFORMS
6.1.8 ADJACENT TECHNOLOGIES
6.1.8.1 Precision medicine
6.1.8.2 Clinical decision support systems
6.1.8.3 Healthcare data analytics
6.2 PATENT ANALYSIS
6.2.1 PATENT PUBLICATION TRENDS FOR THE MHEALTH SOLUTIONS
6.2.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.3 FUTURE APPLICATIONS
6.3.1 AI-POWERED PREDICTIVE HEALTH MONITORING
6.3.2 PERSONALIZED DIGITAL HEALTH COACHING
6.3.3 CONTINUOUS REMOTE PATIENT MONITORING
6.3.4 AI-ENABLED EARLY DISEASE DETECTION
6.3.5 MOBILE MEDICATION ADHERENCE AND MANAGEMENT
6.4 IMPACT OF AI/GEN AI ON MHEALTH SOLUTIONS MARKET
6.4.1 INTRODUCTION
6.4.2 MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS MARKET
6.4.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.4.3.1 Cottage health expands AI-assisted virtual care and patient safety platform enterprise-wide
6.4.3.2 Apollo Hospitals deploys AI-enabled connected care across healthcare continuum
6.4.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
6.4.4.1 AI-powered symptom assessment & triage
6.4.4.2 Predictive health analytics
6.4.4.3 Conversational health assistants
6.4.4.4 Medication & treatment support
6.4.5 USER READINESS AND IMPACT ASSESSMENT
6.4.5.1 User readiness
6.4.5.1.1 Healthcare providers
6.4.5.1.2 Healthcare payers
6.4.5.1.3 Patients/Consumers
6.4.5.2 Impact assessment
6.4.5.2.1 User A: Healthcare providers
6.4.5.2.1.1 Implementation
6.4.5.2.1.2 Impact
6.4.5.2.2 User B: Healthcare payers
6.4.5.2.2.1 Implementation
6.4.5.2.2.2 Impact
6.4.5.2.3 User B: Patients/Consumers
6.4.5.2.3.1 Implementation
6.4.5.2.3.2 Impact
6.4.6 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
6.4.7 REGULATORY ANALYSIS

7.1 INTRODUCTION
7.2 DECISION-MAKING PROCESS
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
7.3.2 BUYING CRITERIA
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
7.5 UNMET NEEDS FROM VARIOUS END USERS
7.5.1 UNMET NEEDS
7.5.2 END USER EXPECTATIONS
7.6 MARKET PROFITABILITY

8.1 INTRODUCTION
8.2 MHEALTH APPS
8.2.1 GROWING ADOPTION FOR PERSONALIZED AND CONNECTED HEALTHCARE TO DRIVE SEGMENT
8.2.2 CHRONIC CARE MANAGEMENT APPS
8.2.2.1 Increasing need for continuous, personalized chronic care management to boost demand
8.2.3 MENTAL & BEHAVIORAL HEALTH APPS
8.2.3.1 Growing demand for accessible and convenient mental healthcare to drive segment
8.2.4 GENERAL HEALTH & FITNESS APPS
8.2.4.1 Focus on personalized health, fitness, and wellness management to propel segment
8.2.5 MEDICATION MANAGEMENT & ADHERENCE APPS
8.2.5.1 Segment driven by need for improved medication adherence and treatment management
8.2.6 WOMEN’S HEALTH APPS
8.2.6.1 Rapid adoption of mobile technologies for personalized women’s health management
8.2.7 DIAGNOSTIC & SYMPTOM CHECKER APPS
8.2.7.1 Increasing need for convenient digital health assessment and diagnostic support to drive segment
8.2.8 PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS
8.2.8.1 Growing need for accessible and connected patient health information to boost market
8.2.9 CLINICAL DECISION SUPPORT APPS
8.2.9.1 Rapid adoption of medical applications for clinical monitoring and decision support to drive segment
8.2.10 OTHER HEALTHCARE APPS
8.2.10.1 High demand for digital healthcare information and patient engagement to grow market
8.3 CONNECTED MEDICAL DEVICES
8.3.1 ADVANCING CONNECTED TECHNOLOGIES FOR CONTINUOUS AND PERSONALIZED HEALTH MONITORING TO DRIVE MARKET
8.3.2 VITAL SIGNS MONITORING DEVICES
8.3.2.1 Expanding role of connected monitoring in continuous patient assessment to boost segment
8.3.3 SLEEP MONITORING DEVICES
8.3.3.1 Advancing connected technologies for sleep health management
8.3.4 MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES
8.3.4.1 Increasing integration of multiparameter monitoring across care settings to boost market
8.3.5 FETAL & MATERNAL MONITORING DEVICES
8.3.5.1 Enhanced maternal and fetal care through wireless monitoring to drive segment
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.6.1 Segment driven by advances in connected technologies for neurological monitoring
8.3.7 SMART INHALERS & DRUG DELIVERY DEVICES
8.3.7.1 Improved medication management through connected drug delivery to boost market
8.3.8 OTHER CONNECTED MEDICAL DEVICES
8.3.8.1 Broadening applications of connected devices in specialized healthcare
8.4 MHEALTH SERVICES
8.4.1 EXPANDING ACCESS TO CONNECTED AND PATIENT-CENTRIC HEALTHCARE SERVICES TO BOOST MARKET
8.4.2 REMOTE PATIENT MONITORING SERVICES
8.4.2.1 Extending clinical oversight beyond traditional care settings -key driver
8.4.3 TELEHEALTH SERVICES
8.4.3.1 Broad access to virtual and on-demand healthcare to boost demand
8.4.4 DIGITAL DISEASE MANAGEMENT SERVICES
8.4.4.1 Shifting chronic disease management toward continuous digital care
8.4.5 OTHERS
8.4.5.1 Connected care strengthened through implementation, support, and digital rehabilitation

9.1 INTRODUCTION
9.2 PREVENTIVE CARE & WELLNESS
9.2.1 AI AND WEARABLES DRIVE PREVENTIVE MHEALTH ADOPTION
9.3 SCREENING & DIAGNOSIS
9.3.1 MOBILE AND AI-ENABLED TOOLS EXPANDING ACCESS TO EARLY SCREENING & DIAGNOSIS
9.4 TREATMENT & DISEASE MANAGEMENT
9.4.1 CONNECTED DEVICES AND DIGITAL THERAPEUTICS STRENGTHENING MHEALTH-BASED DISEASE MANAGEMENT
9.5 PATIENT MONITORING
9.5.1 WEARABLES AND REMOTE MONITORING ENABLE CONTINUOUS PATIENT OVERSIGHT
9.6 MEDICATION MANAGEMENT & ADHERENCE
9.6.1 MOBILE PLATFORMS AND DIGITAL TOOLS IMPROVING MEDICATION ADHERENCE
9.7 CONSULTING & CARE COORDINATION
9.7.1 DIGITAL CONNECTIVITY ENABLES ENHANCED COORDINATED CARE DELIVERY
9.8 REHABILITATION & RECOVERY
9.8.1 DIGITAL REHABILITATION EXTENDS RECOVERY BEYOND TRADITIONAL THERAPY SETTINGS
9.9 OTHERS
9.9.1 MOBILE HEALTH EXPANDS POPULATION-LEVEL HEALTH EDUCATION AND AWARENESS

10.1 INTRODUCTION
10.2 PATIENTS/CONSUMERS
10.2.1 PERSONALIZED AND CONVENIENT HEALTHCARE TO LEAD TO MARKET GROWTH
10.3 HEALTHCARE PROVIDERS
10.3.1 HEALTHCARE PROVIDERS INTEGRATING MHEALTH INTOCONNECTED CARE DELIVERY
10.4 HEALTHCARE PAYERS
10.4.1 LEVERAGING MHEALTH TO IMPROVE OUTCOMES ANDMANAGE HEALTHCARE COSTS
10.5 OTHER END USERS
10.5.1 SCALED MHEALTH FOR POPULATION-LEVEL HEALTHCARE TO DRIVE SEGMENT

11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Market driven by RPM and telehealth expansion
11.2.3 CANADA
11.2.3.1 Market driven by digital adoption and interoperability
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 DiGA reimbursement and digital health integration to drive market
11.3.3 UK
11.3.3.1 Market driven by NHS digitalization and AI adoption
11.3.4 FRANCE
11.3.4.1 Market driven by telemonitoring and digital health infrastructure
11.3.5 ITALY
11.3.5.1 Market driven by PNRR, telemedicine, and EHR expansion
11.3.6 SPAIN
11.3.6.1 Rising funding for digital health plans to boost market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Market driven by internet healthcare and AI-enabled care
11.4.3 JAPAN
11.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market
11.4.4 INDIA
11.4.4.1 Government initiatives and digital health to drive market growth
11.4.5 AUSTRALIA
11.4.5.1 Growing remote monitoring and connected health records expansion to drive market
11.4.6 SOUTH KOREA
11.4.6.1 Strategic partnerships and AI innovations accelerating mHealth adoption
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Market driven by SUS digitalization and connected care
11.5.3 MEXICO
11.5.3.1 Market driven by AI-enabled chronic care
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.7.1 GCC
11.7.1.1 Market driven by virtual hospitals and AI-enabled care
11.7.2 SAUDI ARABIA
11.7.2.1 Expanding connected healthcare ecosystem to boost market
11.7.3 UAE
11.7.3.1 Connected records and smart health apps to boost market
11.7.4 REST OF GCC
11.7.4.1 Strengthening of connected healthcare ecosystems through digital health transformation to propel market
11.7.5 SOUTH AFRICA
11.7.5.1 Market driven by mobile health and digital public healthcare
11.7.6 REST OF MIDDLE EAST & AFRICA

12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET
12.3 REVENUE ANALYSIS, 2021-2025
12.4 MARKET SHARE ANALYSIS, 2025
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
12.5.5.1 Company footprint
12.5.5.2 Regional footprint
12.5.5.3 Offering footprint
12.5.5.4 Use case footprint
12.5.5.5 End user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Company footprint (startups/SMEs)
12.7 COMPANY VALUATION AND FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 OTHER DEVELOPMENTS

13.1 KEY PLAYERS
13.1.1 KONINKLIJKE PHILIPS N.V.
13.1.1.1 Business overview
13.1.1.2 Products & services offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches & approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.3.4 Other developments
13.1.1.4 Analyst's view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 MEDTRONIC
13.1.2.1 Business overview
13.1.2.2 Products & services offered
13.1.2.3 Recent developments
13.1.2.3.1 Product/Service launches & approvals
13.1.2.3.2 Deals
13.1.2.4 Analyst's view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 ABBOTT
13.1.3.1 Business overview
13.1.3.2 Products & services offered
13.1.3.3 Recent developments
13.1.3.3.1 Product/Service launches & approvals
13.1.3.3.2 Deals
13.1.3.4 Analyst's view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 RESMED
13.1.4.1 Business overview
13.1.4.2 Products & services offered
13.1.4.3 Recent developments
13.1.4.3.1 Product/Service launches & approvals
13.1.4.3.2 Deals
13.1.4.4 Analyst's view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 DEXCOM, INC.
13.1.5.1 Business overview
13.1.5.2 Products & services offered
13.1.5.3 Recent developments
13.1.5.3.1 Product/Service launches & approvals
13.1.5.3.2 Deals
13.1.5.4 Analyst's view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 GE HEALTHCARE
13.1.6.1 Business overview
13.1.6.2 Products & services offered
13.1.6.3 Recent developments
13.1.6.3.1 Product/Service launches & approvals
13.1.6.3.2 Deals
13.1.6.3.3 Other developments
13.1.7 OMRON HEALTHCARE, INC.
13.1.7.1 Business overview
13.1.7.2 Products & services offered
13.1.7.3 Recent developments
13.1.7.3.1 Product/Service launches & approvals
13.1.7.4 Recent developments
13.1.7.4.1 Deals
13.1.8 ORACLE
13.1.8.1 Business overview
13.1.8.2 Products & services offered
13.1.8.3 Recent developments
13.1.8.3.1 Product/Service launches & approvals
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 BOSTON SCIENTIFIC CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products & services offered
13.1.9.3 Recent developments
13.1.9.3.1 Product/Service launches & approvals
13.1.9.4 Recent developments
13.1.9.4.1 Deals
13.1.10 SIEMENS HEALTHCARE PRIVATE LIMITED
13.1.10.1 Business overview
13.1.10.2 Products & services offered
13.1.10.3 Recent developments
13.1.10.3.1 Product/Service launches & approvals
13.1.10.3.2 Expansions
13.1.11 OPTUM
13.1.11.1 Business overview
13.1.11.2 Products & services offered
13.1.11.3 Recent developments
13.1.11.3.1 Deals
13.1.12 ATHENAHEALTH
13.1.12.1 Business overview
13.1.12.2 Products & services offered
13.1.12.3 Recent developments
13.1.12.3.1 Product/Service launches & approvals
13.1.12.3.2 Deals, January 2023-July 2026
13.1.13 EMPATICA INC.
13.1.13.1 Business overview
13.1.13.2 Products & services offered
13.1.13.3 Recent developments
13.1.13.3.1 Product/Service launches & approvals
13.1.13.3.2 Deals
13.1.13.3.3 Expansions
13.1.14 TELADOC HEALTH, INC.
13.1.14.1 Business overview
13.1.14.2 Products & services offered
13.1.14.3 Recent developments
13.1.14.3.1 Product/Service launches & approvals
13.1.14.3.2 Deals
13.1.15 WELLDOC, INC.
13.1.15.1 Business overview
13.1.15.2 Products & services offered
13.1.15.3 Recent developments
13.1.15.3.1 Product/Service launches & approvals
13.1.15.3.2 Deals
13.1.16 ALIVECOR, INC.
13.1.16.1 Business overview
13.1.16.2 Products & services offered
13.1.16.3 Recent developments
13.1.16.3.1 Product/Service launches & approvals
13.1.16.3.2 Deals
13.1.17 BIOFOURMIS
13.1.17.1 Business overview
13.1.17.2 Products & services offered
13.1.17.3 Recent developments
13.1.17.3.1 Deals
13.1.18 TUNSTALL GROUP
13.1.18.1 Business overview
13.1.18.2 Products & services offered
13.1.19 GARMIN LTD.
13.1.19.1 Business overview
13.1.19.2 Products & services offered
13.1.19.3 Recent developments
13.1.19.3.1 Product/Service launches & approvals
13.1.19.3.2 Deals
13.1.20 AIRSTRIP TECHNOLOGIES, INC
13.1.20.1 Business overview
13.1.20.2 Products & services offered
13.1.20.3 Recent developments
13.1.20.3.1 Product/Service launches & approvals
13.1.20.3.2 Deals
13.2 OTHER PLAYERS
13.2.1 NATURAL CYCLES NORDIC AB
13.2.2 SIDEKICK HEALTH
13.2.3 BUOY HEALTH, INC.
13.2.4 VIASUALDX
13.2.5 FIMO HEALTH

14.1 RESEARCH DATA
14.1.1 SECONDARY DATA
14.1.1.1 Key data from secondary sources
14.1.2 PRIMARY DATA
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primary sources
14.2 MARKET SIZE ESTIMATION
14.3 MARKET SIZE ESTIMATION
14.4 MARKET BREAKDOWN DATA TRIANGULATION
14.5 MARKET SHARE ESTIMATION
14.6 STUDY ASSUMPTIONS
14.7 RESEARCH LIMITATIONS
14.7.1 METHODOLOGY-RELATED LIMITATIONS
14.8 RISK ASSESSMENT

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

TABLE 1 USD EXCHANGE RATES
TABLE 2 MHEALTH SOLUTIONS MARKET: IMPACT ANALYSIS
TABLE 3 MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 MHEALTH SOLUTIONS MARKET: ROLE IN ECOSYSTEM
TABLE 5 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025)
TABLE 6 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY REGION (2025)
TABLE 7 MHEALTH SOLUTIONS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 8 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 9 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR MHEALTH SOLUTIONS MARKET
TABLE 10 MHEALTH SOLUTIONS MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 16 NORTH AMERICA: REGULATORY ANALYSIS
TABLE 17 EUROPE: REGULATORY ANALYSIS
TABLE 18 ASIA PACIFIC: REGULATORY ANALYSIS
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
TABLE 20 LATIN AMERICA: REGULATORY ANALYSIS
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OFTOP THREE END USERS (%)
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 23 UNMET NEEDS IN MHEALTH SOLUTIONS MARKET
TABLE 24 END USER EXPECTATIONS IN MHEALTH SOLUTIONS MARKET
TABLE 25 MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 26 MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 27 MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY REGION,2024-2031 (USD MILLION)
TABLE 28 MHEALTH SOLUTIONS MARKET FOR CHRONIC CARE MANAGEMENT APPS,BY REGION, 2024-2031 (USD MILLION)
TABLE 29 MHEALTH SOLUTIONS MARKET FOR MENTAL & BEHAVIORAL HEALTH APPS,BY REGION, 2024-2031 (USD MILLION)
TABLE 30 MHEALTH SOLUTIONS MARKET FOR GENERAL HEALTH & FITNESS APPS,BY REGION, 2024-2031 (USD MILLION)
TABLE 31 MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT &ADHERENCE APPS, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 MHEALTH SOLUTIONS MARKET FOR WOMEN’S HEALTH APPS, BY REGION,2024-2031 (USD MILLION)
TABLE 33 MHEALTH SOLUTIONS MARKET FOR DIAGNOSTIC & SYMPTOM CHECKER APPS,BY REGION, 2024-2031 (USD MILLION)
TABLE 34 MHEALTH SOLUTIONS MARKET FOR PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS, BY REGION, 2024-2031 (USD MILLION)
TABLE 35 MHEALTH SOLUTIONS MARKET FOR CLINICAL DECISION SUPPORT APPS,BY REGION, 2024-2031 (USD MILLION)
TABLE 36 MHEALTH SOLUTIONS MARKET FOR OTHER HEALTHCARE APPS, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 38 MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 MHEALTH SOLUTIONS MARKET FOR VITAL SIGNS MONITORING DEVICES,BY REGION, 2024-2031 (USD MILLION)
TABLE 40 MHEALTH SOLUTIONS MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 41 MHEALTH SOLUTIONS MARKET FOR MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 MHEALTH SOLUTIONS MARKET FOR FETAL & MATERNAL MONITORING DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 MHEALTH SOLUTIONS MARKET FOR NEUROLOGICAL MONITORING DEVICES,BY REGION, 2024-2031 (USD MILLION)
TABLE 44 MHEALTH SOLUTIONS MARKET FOR SMART INHALERS & DRUG DELIVERY DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 MHEALTH SOLUTIONS MARKET FOR OTHER CONNECTED MEDICAL DEVICES,BY REGION, 2024-2031 (USD MILLION)
TABLE 46 MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 47 MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY REGION,2024-2031 (USD MILLION)
TABLE 48 MHEALTH SOLUTIONS MARKET FOR REMOTE PATIENT MONITORING SERVICES,BY REGION, 2024-2031 (USD MILLION)
TABLE 49 MHEALTH SOLUTIONS MARKET FOR TELEHEALTH SERVICES, BY REGION,2024-2031 (USD MILLION)
TABLE 50 MHEALTH SOLUTIONS MARKET FOR DIGITAL DISEASE MANAGEMENT SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 MHEALTH SOLUTIONS MARKET FOR OTHER SERVICES, BY REGION,2024-2031 (USD MILLION)
TABLE 52 MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 53 MHEALTH SOLUTIONS MARKET FOR PREVENTIVE CARE & WELLNESS, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 MHEALTH SOLUTIONS MARKET FOR SCREENING & DIAGNOSIS, BY REGION,2024-2031 (USD MILLION)
TABLE 55 MHEALTH SOLUTIONS MARKET FOR TREATMENT & DISEASE MANAGEMENT,BY REGION, 2024-2031 (USD MILLION)
TABLE 56 MHEALTH SOLUTIONS MARKET FOR PATIENT MONITORING, BY REGION,2024-2031 (USD MILLION)
TABLE 57 MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT & ADHERENCE, BY REGION, 2024-2031 (USD MILLION)
TABLE 58 MHEALTH SOLUTIONS MARKET FOR CONSULTING & CARE COORDINATION,BY REGION, 2024-2031 (USD MILLION)
TABLE 59 MHEALTH SOLUTIONS MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 MHEALTH SOLUTIONS MARKET FOR OTHER USE CASES, BY REGION,2024-2031 (USD MILLION)
TABLE 61 MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 62 MHEALTH SOLUTIONS MARKET FOR PATIENTS/CONSUMERS, BY REGION,2024-2031 (USD MILLION)
TABLE 63 MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY REGION,2024-2031 (USD MILLION)
TABLE 64 MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY REGION,2024-2031 (USD MILLION)
TABLE 65 MHEALTH SOLUTIONS MARKET FOR OTHER END USERS, BY REGION,2024-2031 (USD MILLION)
TABLE 66 MHEALTH SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 68 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 69 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 70 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTEDMEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 71 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 72 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 73 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 74 US: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 75 US: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 76 US: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 77 US: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 78 US: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 79 US: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 80 CANADA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 81 CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 82 CANADA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 83 CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 84 CANADA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 85 CANADA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 86 EUROPE: MHEALTH SOLUTIONS MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 87 EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 88 EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 89 EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 90 EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 91 EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 92 EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 93 GERMANY: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 94 GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 95 GERMANY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 96 GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 97 GERMANY: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 98 GERMANY: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 99 UK: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 100 UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 101 UK: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 102 UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 103 UK: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 104 UK: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 105 FRANCE: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 106 FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 107 FRANCE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 109 FRANCE: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 110 FRANCE: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 111 ITALY: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 112 ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 113 ITALY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 115 ITALY: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 116 ITALY: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 117 SPAIN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 118 SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 119 SPAIN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 120 SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 121 SPAIN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 122 SPAIN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 123 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 124 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 125 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 126 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 127 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 128 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 129 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 130 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 134 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 136 CHINA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 137 CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 138 CHINA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 140 CHINA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 141 CHINA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 142 JAPAN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 143 JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 144 JAPAN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 146 JAPAN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 147 JAPAN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 148 INDIA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 149 INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 150 INDIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 151 INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 152 INDIA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 153 INDIA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 154 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 155 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 156 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 159 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 160 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 161 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 162 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 165 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 168 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 172 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 173 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 174 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 175 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 177 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 178 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 179 BRAZIL: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 180 BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 181 BRAZIL: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 183 BRAZIL: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 184 BRAZIL: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 185 MEXICO: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 186 MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 187 MEXICO: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 MEXICO: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 190 MEXICO: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 191 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 192 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 196 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 204 GCC: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 205 GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 206 GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 207 GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 209 GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 210 GCC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 211 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 212 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR CONNECTEDMEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 214 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 215 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 216 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 217 UAE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 218 UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,2024-2031 (USD MILLION)
TABLE 219 UAE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,2024-2031 (USD MILLION)
TABLE 221 UAE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024-2031 (USD MILLION)
TABLE 222 UAE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 223 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 224 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 228 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 229 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 230 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,2024-2031 (USD MILLION)
TABLE 234 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 235 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 236 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 239 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,BY USE CASE, 2024-2031 (USD MILLION)
TABLE 240 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, JANUARY 2023-JUNE 2026
TABLE 242 MHEALTH SOLUTIONS MARKET SHARE ANALYSIS, 2025
TABLE 243 MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT, 2025
TABLE 244 MHEALTH SOLUTIONS MARKET: OFFERING FOOTPRINT, 2025
TABLE 245 MHEALTH SOLUTIONS MARKET: USE CASE FOOTPRINT, 2025
TABLE 246 MHEALTH SOLUTIONS MARKET: END USER FOOTPRINT, 2025
TABLE 247 MHEALTH SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2025
TABLE 248 MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT (STARTUPS/SMES), 2025
TABLE 249 MHEALTH SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
TABLE 250 MHEALTH SOLUTIONS MARKET: DEALS, JANUARY 2023-AUGUST 2026
TABLE 251 MHEALTH SOLUTIONS MARKET: EXPANSIONS, JANUARY 2023-AUGUST 2026
TABLE 252 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 253 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
TABLE 254 KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
TABLE 255 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026
TABLE 256 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-JULY 2026,JANUARY 2023-AUGUST 2026
TABLE 257 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,JANUARY 2023-AUGUST 2026
TABLE 258 MEDTRONIC: COMPANY OVERVIEW
TABLE 259 MEDTRONIC: PRODUCTS & SERVICES OFFERED
TABLE 260 MEDTRONIC: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 261 MEDTRONIC: DEALS, JANUARY 2023-AUGUST 2026
TABLE 262 ABBOTT: COMPANY OVERVIEW
TABLE 263 ABBOTT: PRODUCTS & SERVICES OFFERED
TABLE 264 ABBOTT: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 265 ABBOTT: DEALS, JANUARY 2023-AUGUST 2026
TABLE 266 RESMED: COMPANY OVERVIEW
TABLE 267 RESMED: PRODUCTS & SERVICES OFFERED
TABLE 268 RESMED: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 269 RESMED, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 270 DEXCOM, INC.: COMPANY OVERVIEW
TABLE 271 DEXCOM, INC.: PRODUCTS & SERVICES OFFERED
TABLE 272 DEXCOM, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 273 DEXCOM, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 274 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 275 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 276 GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 277 GE HEALTHCARE: DEALS, JANUARY 2023-AUGUST 2026
TABLE 278 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023-AUGUST 2026
TABLE 279 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW
TABLE 280 OMRON HEALTHCARE, INC.: PRODUCTS & SERVICES OFFERED
TABLE 281 OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
TABLE 282 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 283 ORACLE: COMPANY OVERVIEW
TABLE 284 ORACLE: PRODUCTS & SERVICES OFFERED
TABLE 285 ORACLE: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 286 ORACLE: DEALS, JANUARY 2023-AUGUST 2026
TABLE 287 ORACLE: EXPANSIONS, JANUARY 2023-AUGUST 2026
TABLE 288 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 289 BOSTON SCIENTIFIC CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 290 BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
TABLE 291 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
TABLE 292 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 293 SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCTS & SERVICES OFFERED
TABLE 294 SIEMENS HEALTHINEERS: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 295 SIEMENS HEALTHCARE PRIVATE LIMITED: EXPANSIONS,JANUARY 2023-AUGUST 2026
TABLE 296 OPTUM: COMPANY OVERVIEW
TABLE 297 OPTUM: PRODUCTS & SERVICES OFFERED
TABLE 298 OPTUM: DEALS, JANUARY 2023-AUGUST 2026
TABLE 299 ATHENAHEALTH: COMPANY OVERVIEW
TABLE 300 ATHENAHEALTH: PRODUCTS & SERVICES OFFERED
TABLE 301 ATHENAHEALTH: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 302 ATHENAHEALTH: DEALS, JANUARY 2023-AUGUST 2026
TABLE 303 EMPATICA INC.: COMPANY OVERVIEW
TABLE 304 EMPATICA INC.: PRODUCTS & SERVICES OFFERED
TABLE 305 EMPATICA INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 306 EMPATICA INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 307 EMPATICA INC.: EXPANSIONS, JANUARY 2023-AUGUST 2026
TABLE 308 TELADOC HEALTH, INC.: COMPANY OVERVIEW
TABLE 309 TELADOC HEALTH, INC.: PRODUCTS & SERVICES OFFERED
TABLE 310 TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 311 TELADOC HEALTH, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 312 WELLDOC, INC.: COMPANY OVERVIEW
TABLE 313 WELLDOC, INC.: PRODUCTS & SERVICES OFFERED
TABLE 314 WELLDOC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 315 WELLDOC, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 316 ALIVECOR, INC. COMPANY OVERVIEW
TABLE 317 ALIVECOR, INC. PRODUCTS & SERVICES OFFERED
TABLE 318 ALIVECOR, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 319 ALIVECOR, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 320 BIOFOURMIS: COMPANY OVERVIEW
TABLE 321 BIOFOURMIS: PRODUCTS & SERVICES OFFERED
TABLE 322 BIOFOURMIS: DEALS, JANUARY 2023-AUGUST 2026
TABLE 323 TUNSTALL GROUP: COMPANY OVERVIEW
TABLE 324 TUNSTALL GROUP: PRODUCTS & SERVICES OFFERED
TABLE 325 GARMIN LTD.: COMPANY OVERVIEW
TABLE 326 GARMIN LTD.: PRODUCTS & SERVICES OFFERED
TABLE 327 GARMIN LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS,JANUARY 2023-AUGUST 2026
TABLE 328 GARMIN LTD.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 329 AIRSTRIP TECHNOLOGIES, INC: COMPANY OVERVIEW
TABLE 330 AIRSTRIP TECHNOLOGIES, INC: PRODUCTS & SERVICES OFFERED
TABLE 331 AIRSTRIP TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
TABLE 332 AIRSTRIP TECHNOLOGIES, INC.: DEALS, JANUARY 2023-AUGUST 2026
TABLE 333 RISK ASSESSMENT: MHEALTH SOLUTIONS MARKET

FIGURE 1 MHEALTH SOLUTIONS MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL MHEATLH SOLUTIONS MARKET, 2024-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MHEATLHSOLUTIONS MARKET, 2022-2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF MHEATLH SOLUTIONS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN MHEATLH SOLUTIONS MARKET, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MHEATLH SOLUTIONS MARKET DURING FORECAST PERIOD
FIGURE 8 GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
FIGURE 9 MHEALTH APPS IN NORTH AMERICA ACCOUNTED FOR LARGESTMARKET SHARE IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 MHEALTH SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 13 MHEALTH SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 MHEALTH SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS FOR MHEALTH SOLUTIONS MARKET
FIGURE 18 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MHEALTH MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 19 MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS
FIGURE 20 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 23 NORTH AMERICA: MHEALTH SOLUTIONS MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET SNAPSHOT
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET,2021-2025
FIGURE 26 MHEALTH SOLUTIONS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27 RANKING OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, 2025
FIGURE 28 MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX(KEY PLAYERS), 2025
FIGURE 29 MHEALTH SOLUTIONS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 30 MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31 EV/EBITDA OF KEY VENDORS, 2026
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETAOF KEY VENDORS, 2026
FIGURE 33 MHEALTH SOLUTIONS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2025)
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 37 RESMED: COMPANY SNAPSHOT (2026)
FIGURE 38 DEXCOM, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
FIGURE 40 OMRON HEALTHCARE: COMPANY SNAPSHOT (2024)
FIGURE 41 ORACLE: COMPANY SNAPSHOT (2026)
FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 43 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2025)
FIGURE 44 OPTUM: COMPANY SNAPSHOT (2025)
FIGURE 45 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2025)
FIGURE 46 GARMIN LTD.: COMPANY SNAPSHOT (2025)
FIGURE 47 RESEARCH DESIGN
FIGURE 48 PRIMARY SOURCES
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,DESIGNATION, AND REGION
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 CAGR PROJECTIONS FROM ANALYSIS OF DROC IN MHEALTH SOLUTIONS INDUSTRY
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 56 DATA TRIANGULATION METHODOLOGY